ABSTRACT
in the aged mice, there were no age-dependent differences in either microglia or spleen following 48 a subsequent LPS dose, suggesting that animals at this age retain the ability to effectively control 49 their immune response following repeated challenge. The exacerbated microglial immune 50 response to systemic inflammation at early middle-age suggests that the CNS may be vulnerable 51 to age-dependent alterations earlier than previously appreciated. clinical symptoms by several years to several decades (24), indicating that middle-age may be an 84 especially sensitive or critical period for the development of these diseases. Thus, changes in 85 microglia during the middle-age period, and its associated para-inflammation, may be important 86 factors in the etiology of neurodegenerative disorders. Whereas age-related alterations in 87 microglia are well-documented in animal models of aging (>18-20 month-old mice and rats) it is 88 not clear at what age these changes begin to occur. Thus, in this study, we tested the hypotheses 89 that: 1) microglial responses to an initial inflammatory challenge will be elevated in middle-aged 90 mice (9-10 months) compared to young adult mice (2 months), and 2) microglia from middle-91 aged mice will display properties of senescence involving stronger pro-inflammatory responses 92 to a subsequent systemic inflammatory challenge. While microglial responses to repeated 93 inflammatory challenge have been previously tested in vitro, they have not to our knowledge 94 been tested in vivo, or in aged animals. To test these hypotheses, we used a model of repeated 
METHODS

100
Animals
101
Male ICR/CD1 mice were purchased from Charles River (Wilmington, MA, USA) and 102 housed in AAALAC-accredited facilities under standard 12 hour light/dark cycles with water and 103 food available ad libitum. To study the effect of age, 2 month-old (young) and 9-10 month old
104
(middle-aged) adult mice were used (19) . All experiments were conducted under protocols 
Microglial isolation
116
Microglia were isolated from brains as we have described in detail previously (36).
117
Briefly: after perfusion with PBS, brains (including brain stem and cerebellum) were dissected, 118 weighed and enzymatically digested using Trypsin supplemented with DNase I for 20 min. 
RNA extraction and qRT-PCR
129
Total RNA was extracted from isolated microglial cells or spleen tissue using Reagent (Sigma, MO, USA) according to the manufacturer's protocol. RNA was reverse 131 transcribed to cDNA using MMLV reverse transcriptase (Invitrogen, Grand Island, NY). This 132 was followed by quantitative PCR using SYBR Green solution (Applied Biosystems, CA, USA).
133
Primer sequences are provided in Table 1 
RESULTS
158
Microglial cell number and basal gene expression does not differ between young and 159 middle-aged naïve mice 160 The yield of isolated microglia from the healthy brain was similar in young (1589 ± 363 161 cells/mg tissue) and middle-aged (1475 ± 420 cells/mg tissue) mice (Fig 1A) . Microglia 162 expressed low levels of CD45 as determined by flow cytometry, and there were no age-related 163 differences (Fig 1B; left panels 0hr). We also evaluated basal gene expression of typical M1 and 164 M2 markers. There were no age-dependent differences noted in basal gene expression (0 hr, first 165 arrow) of the M1 markers inducible nitric oxide synthase (iNos; Fig 2A) , tumor necrosis factor 166 alpha (Tnfα; Fig 2B) , interleukin (Il)-6 (Fig 2C) or Il-1β (Fig 2D) . Also there were no 167 differences in basal microglial gene expression (0 hr, first arrow) of the M2 markers Il-10 (Fig   168   3A) , arginase-1 (Fig 3B) or Ym1 (Fig 3C) injection, and was further increased to 36% by 24 hours after LPS (Fig. 1A, solid line) . In 178 middle-aged mice, microglial cell number was not statistically increased at either 3 or 24 hours 179 following LPS exposure (Fig 1A, dotted line) , although there was a slight trend 17% and 9% 180 towards an increase respectively, at each time point. There were no differences in CD45 protein 181 levels analyzed by flow cytometry in microglia from young and middle-aged animals, and their 182 response to LPS was also similar (Fig 1B-D) . The lack of significant changes in young adult 183 microglial CD45 levels at 3 or 24 hours after LPS injection suggests that macrophage influx is 184 unlikely to be responsible for the increase in CD11b + cell number observed in the brain at these 185 time points.
186
In both young and aging mice, LPS-induced systemic inflammation resulted in significant 187 upregulation of all M1 pro-inflammatory genes tested in microglia 3 hours after LPS 188 administration (Fig 2) . While there were no age-dependent differences in the magnitude of iNos 189 up-regulation (Fig 2A) , there were differences in the mRNA levels of the cytokines Tnfα (Fig   190   2B ), Il-6 ( Fig 2C) and Il-1β ( Fig 2D) which were significantly higher in microglia from the older 191 animals. By 24 hours post-LPS injection, the expression of all pro-inflammatory genes had 192 returned close to baseline levels, although Tnfα and Il-1β still remained significantly elevated.
193
The expression of the anti-inflammatory cytokine Il-10 followed a similar expression pattern to 194 the pro-inflammatory cytokines with highest levels being observed 3 hours after LPS injection; 195 however, there was no significant difference in Il-10 mRNA levels between young and middle-196 aged mice (p=0.073, n=6-7) ( Fig 3A) . By 24 hours after LPS injection, Il-10 mRNA levels had 197 returned to baseline levels in microglia from both ages. The expression of other markers of the 198 M2 phenotype arginase-1 (Fig 3B) and Ym1 ( Fig 3C) was not significantly changed at 3 hours 199 after LPS in microglia from mice of either age. Interestingly, however, 24h after LPS injection 200 when Il-10 mRNA levels were significantly down-regulated from their peak at 3 hours post-201 injection, the expression of arginase-1 was significantly upregulated by 14 and 22 times in 202 young and aging mice, respectively, whereas Ym1 expression was not affected.
203
We also analyzed the expression of Tlr2 and Tlr4 in microglia from young and middle- ages relative to expression at baseline ( Fig 4B) ; basal Tlr4 levels did not differ by age (p=0.787).
209
We found that the expression of Tlr4 was decreased by 40% after 3 hours of LPS injection in 210 mice of both ages, an effect that was maintained for at least for 24 hours after LPS 211 administration.
213
Microglial responses to repeated systemic LPS administration are similar in young and 214 older mice 215 We hypothesized that since the cytokine response to the first dose of LPS was greater in 216 middle-aged microglia, that repeated stimulation of these primed microglia may reveal further 217 differences in responsiveness between young and middle-aged mice. Thus, a second dose of LPS 218 was delivered intraperitoneally 24 hours after the first injection when the expression of the pro-219 inflammatory genes measured here had almost returned to baseline levels. Microglial responses 220 to this second LPS challenge were evaluated 3 hours later. Contrary to the responses to the first 221 LPS dose, we did not observe an increase in microglial number following the second injection of 222 LPS in mice of either age (Fig 1A) . CD45 levels on CD11b were increased (Fig 1B-D) , although there was no observable population of distinctly CD45 high 224 cells that would suggest macrophage infiltration. Rather, our data suggest an upregulation of cell 225 surface CD45 levels by resident microglia. The M1 inflammatory gene response of microglia to 226 the second LPS challenge was at least as strong as it was to the first LPS injection (Fig 2A-D) , 227 but this time we did not observe statistically significant differences with age, with the exception 228 of Tnfα gene expression (Fig. 2B ) which was higher in middle-aged microglia. Arginase-1 229 mRNA levels were high in both ages following the first LPS injection, and they remained 230 upregulated after the second stimulation (Fig 3B) . Although the expression of Ym1 was 231 unaffected by the first LPS injection, its mRNA levels were significantly increased after the 232 second dose of LPS (Fig 3C) , and no age-dependent differences were observed.
233
Tlr2 (Fig 4A) and Tlr4 (Fig 4B) expression was not different following the second LPS 234 challenge (LPS 24+3h), and there was no difference observed with age. While Tlr2 mRNA levels 235 at 24 hrs were either returning to or were already at baseline both ages, the second LPS challenge 236 induced an increase in Tlr2 expression in microglia from both ages that was not different from 
247
Whereas basal pro-inflammatory gene expression in the spleen was similar in mice of both ages, 248 with regard to Ifnγ (Fig 5A) , Il-1β (Fig 5B) and Tnfα (Fig 5C) mRNA levels, there were 249 differences in the magnitude of the responses between young and aging mice. The first dose of 250 LPS induced a strong up-regulation of Ifnγ (Fig 5A) in spleens of mice from both ages, but the 251 response in the older mice was significantly higher than in the younger mice (70 vs 25 times, 252 respectively) 3 hours after LPS injection. The aging animals also had significantly higher mRNA 253 levels of Il-1β compared to the young adults (Fig 5B) , but there were no age-dependent 254 differences in the expression of Tnfα (Fig 5C) . By 24 hours post-LPS injection, all pro-255 inflammatory genes had significantly returned back to baseline levels in both ages. Interestingly, 256 the second LPS injection did not induce expression of Ifnγ or Tnfα (Fig 5A, C) in the spleen like 257 the first dose, but Il-1β mRNA was significantly upregulated in both young and middle-aged 258 mice by ~2-fold (Fig 5B) . phenotype is already present in 12 month-old animals (6, 14, 27, 30, 38, 48, 54, 59 ). Here we
269
show that some exacerbated pro-inflammatory responses occur as early as 9-10 months of age,
270
and that these exaggerated responses are evident in both splenocytes and microglia, suggesting 271 that age-dependent central and peripheral immune responses are affected earlier than previously 272 thought.
273
Although there were no significant age-related differences detected in basal gene that microglial pro-inflammatory responses to the second LPS challenge are just as strong as the 300 first. Moreover, we found that microglia from both young and middle-aged mice mounted 301 equally strong pro-inflammatory responses to a second LPS challenge. Some differences were 302 noted in the expression of the M2a markers arginase-1 and Ym1 in response to the first and the 303 second LPS injections in mice of both ages; they were higher after the second dose than the first.
304
In macrophages, this phenotype is associated with tissue repair and growth stimulation (18). The 305 upregulation of these M2a molecules in microglia after the second LPS dose suggests that 306 microglia may be polarizing towards the anti-inflammatory phenotype, perhaps to promote tissue 307 healing after repeated inflammatory episodes. Interestingly, the Il-10 response in young and 308 middle-aged adult microglia were not different after either LPS dose, suggesting that the 309 exacerbated IL-10 signaling that has been reported in geriatric mice (18-20 months) (23) does
310 not yet occur in the middle-aged (9-10 month-old) animals used here despite the disparities in 311 some pro-inflammatory cytokines that are already apparent at this age. These data suggest 312 dichotomous regulation of pro-and anti-inflammatory cytokines during aging.
313
The LPS model of systemic inflammation used here is a common inflammatory stimulus Another interesting observation in our study is the downregulation of microglial 332 expression of Tlr4 and the up-regulation of Tlr2 after systemic administration of LPS. We found 333 that Tlr2 mRNA was upregulated in microglia from both young and middle-aged mice. This is 
341
Whereas LPS does not directly cross the BBB, it can increase BBB permeability (4, 47).
342
In addition, BBB epithelial cells can directly respond to LPS by producing large amounts of 343 cytokines such as IL-1β that can be released into the CNS to propagate neuroinflammation (47, were similarly elevated. Reasons for this difference may involve age, as the mice in our study are 365 considerably younger (9-10 months old) than the geriatric mice used in the above study. Further, 366 the mice in our study were an outbred strain (ICR/CD1), so there may be also be strain-367 dependent differences in the interactions between the peripheral and central immune systems; we 368 have previously reported important differences in microglial responses between inbred and 369 outbred mouse strains (37).
370
Systemic inflammation is associated with many conditions such as atherosclerosis, (7, 9, 11, 17, 53) . Understanding how interactions between the peripheral immune 378 system and microglia are influenced by age is critical if we are to begin to identify novel targets 379 to manipulate microglial activities during neurodegenerative disease. 
